Aleksandar Godic reviews the benefits of using autologous adipose-derived stem cells in regenerative medicine.
Advanced age in humans is considered to be the greatest risk factor for a range of diseases, including cancer, Alzheimer’s disease, cardiovascular diseases, atherosclerosis, and metabolic syndrome, to name but a few. There exists the possibility that targeted approaches to anti-ageing will delay the onset of many pathologies that contribute to morbidity in the elderly, and will, therefore, achieve longer life expectancy or at least a healthier and more comfortable ageing1.
Ageing is the result of two overlapping processes, ‘intrinsic’ and ‘extrinsic’ ageing. ‘Intrinsic’ structural changes occur as a consequence of physiological ageing and are genetically determined2,3. The rate of ageing is significantly varied among different individuals and even among different anatomical sites in a single individual. Many theories have tried to explain the ageing process, but the most plausible of these concentrate on DNA damage and the concomitant repair process, which induce genome-wide epigenetic changes leading to cell senescence, loss of proper cell function, and genomic aberrations4. The signals from DNA-breaks lead to three responses regarding cell fate: transient cell cycle arrest (repair), stable cell cycle arrest (senescence), or cell death (apoptosis). Intrinsic (genetically determined or chronological) and extrinsic (UV- and toxic exposure-mediated) ageing processes overlap and are strongly related to increased generation of free radicals in cells, tissues, and organs. The underlying mechanism of both processes is increased oxidative stress, which is probably the single most harmful contributor to ageing, leading to loss of cells and the extracellular matrix5.
Manifestations of ageing
The clinical manifestations of intrinsic ageing reflect the balance between the severity of tissue and organ damage and their regenerative abilities. All proliferating and terminally differentiated cells are susceptible to harmful events leading to intrinsic ageing6.
The signs of ageing generally start early. By 40 years of age, most organs, tissues, and cells gradually become less efficient. The skin becomes thin, transparent, less elastic, and more lined and wrinkled. There is a loss of underlying fat on the face leading to hollowed cheeks and eye sockets. It is normal for hair to gradually thin on the scalp, pubic area, and armpits. As melanocytes decline in number, grey hair growth increases. Nail plates gradually thin7. By age 80, there are visible changes in posture due to compression of joints, spinal bones, and spinal discs. Regarding hearing, high-frequency sounds become harder to hear. Many elderly people develop presbyopia (the lenses in the eyes become less flexible) and a need for reading glasses. As we age, we will sleep less and not as deep compared to when we were younger. As we age, our bones become less dense and weaker. There is also more body fat and less muscle mass due to hormone changes. Problems with memory are normal and common. An elderly individual does not remember names as well as when they were young and has diminished short-term memory. The heart becomes less efficient and needs to overcome bigger resistanc
e as it ages and consequently starts to fail. The lungs supply less oxygen over time. The kidneys decline in function and un-cleared metabolites from medicines and metabolism build-up and cause toxicity. In men, sexual dysfunction is common, and women undergo a number of menopausal changes linked to lower estrogen production. In addition, an inactive lifestyle and unhealthy diet increase the risk of chronic diseases, such as coronary artery disease, osteoarthritis, high blood pressure, obesity, osteoporosis, type 2 diabetes, and cancer.
Stem cells are capable of extensive self-renewal and expansion and have the potential to differentiate into any type of somatic tissue8. They can be used in regenerative medicine, reconstructive surgery, and tissue bioengineering and can be derived from a range of tissues. Embryonic stem cells (ESC) are derived from human embryos from couples that have undergone in vitro fertilization — raising ethical concerns regarding their use. In addition, there is a concern of rejection reactions in non-related donors9.
Induced pluripotent stem cells (iPSC) are derived from modified differentiated adult somatic cells and have the same properties as ESC. They are more acceptable since they are not derived from human embryos but involve major genetic modifications in in vitro conditions before they can be used for research and clinical applications10,11.
Adipose-derived stem cells (ASC)
Autologous adult stem cells are immunocompatible, and there are no ethical concerns related to their use. Multipotent mesenchymal stem cells (MSC), which have similar characteristics to bone marrow derived MSC, are nonhematopoietic cells, which originate from mesoderm and are present in various postnatal organs and connective tissues, including: trabecular bone12, periosteum13, synovial membrane14, skeletal muscle15, skin16, pericytes17, peripheral blood18, deciduous teeth19, periodontal ligament20, and umbilical cord21,22. Adult stem cells derived from these tissues would require ex vivo expansion or manipulation before they could be used clinically, since their quantity in the mentioned tissues is low. It has been found that multipotent stem cells within adipose tissue, termed adipose-derived stem cells23, are one of the most promising stem cell populations identified thus far, since human adipose tissue can be easily harvested through liposuction with only minimal patient discomfort. Therefore, the use of autologous ASC has been shown to be safe and efficacious in preclinical and clinical studies24,25. To date, a number of scientific papers on ASC biology and their use in regenerative medicine have been published, and their efficacy has been determined in several clinical trials24,25.
Localization and cellular characteristics of ASC
Adipose tissue is composed mainly of adipocytes (fat cells), which are clustered into fat lobules26. It consists of mature adipocytes (more than 90% of the tissue volume), and a stromal vascular fraction (SVF). Stromal vascular fraction is composed of pre-adipocytes, fibroblasts, vascular smooth muscle cells, endothelial cells, resident monocytes/macrophages, lymphocytes, and ASC27,28. Characteristics of ASC differ according to the location of the harvested adipose tissue. Most resistant to apoptosis are ASC harvested from superficial abdominal regions, followed by those harvested from medial thigh, trochanteric, and superficial deep abdominal depots29. The density of stem cell varies among different locations and types. They are more abundant in the subcutaneous compartment of white adipose tissue compared to visceral fat30. Likewise, it has been reported that ASC have been found within the brown adipose tissue, which possess skeletal myogenic differentiation potential31.
Freshly isolated stromal vascular cells (SVF) are a heterogeneous cell population that includes ASC, endothelial cells, vascular smooth muscle cells, pericytes, and hematopoietic cells in uncultured conditions32. Freshly isolated SVF and those after a few divisions express higher levels of CD117 (c-kit), human leukocyte antigen DR (HLA-DR), and stem cell-associated markers (e.g. CD34), as well as lower levels of stromal cell markers22,32–48. As they proliferate, they lose CD34 surface antigens44. Adipose-derived stem cells, which express CD34+ have a greater proliferative capacity, while those which do not express CD34- are more plastic33,49.
Adipose-derived stem cells share many cell surface markers with pericytes and bone marrow-MSC33. It has been published that ASC are most likely located within the perivascular tissue since they express pericyte surface antigens50,51. ASC are capable of dividing, self-renewal, and proliferation due to their telomerase activity, which is diminished as they age52. They do not exhibit immunosuppressive properties because they do not express HLA-DR antigens on their cell surfaces53.
The role of ASC in regenerative medicine
Previous studies have suggested that ASC exhibit their beneficial effects (angiogenesis, anti-inflammation, and anti-apoptosis) mostly through secreted cytokines and growth factors rather than their differentiation into various cell types54,55. The ASC cytokines and growth factors have the potential to be used in cell-based treatments in regenerative medicine due to their promotion of fibroblast proliferation and the differentiation of ASC to fibroblast. They also play a role in collagen secretion. In addition, they inhibit tyrosinase and consequently cause whitening of the skin. A number of papers have described the secretory factors of pre-adipocytes, ASC, or adipose tissue56,57. Cultured ASC (after a few divisions), secrete adiponectin, angiotensin, basic fibroblast growth factor (bFGF), cathepsin D, CXCL12, granulocyte-macrophage colony-stimulating factor (GCSF), hepatocyte growth factor (HGF), insulin-like growth factor (IGF)-1, interleukins 6–8 and 11, pentraxin, pregnancy zone protein, retinol-binding protein, transforming growth factor β (TGF-β), tumor necrosis factor α (TNF-α), and vascular endothelial growth factor (VEGF)56, 57, 58.
Proliferation capacity of ASC
Previous reports have shown that ASC double in number between 40 to 120 hours depending on donor age, type of adipose tissue (white or brown), location (subcutaneous or visceral), the harvesting procedure, and culture conditions23, 43, 59, 60. The proliferation capacity of ASC is at its greatest in young individuals and diminishes as we age. In addition, ASC also gradually lose proliferative capacity in in vitro conditions60. Senescence of ASC is similar to that witnessed in bone marrow-derived MSC59. Adipose-derived stem cells remain stable as they proliferate in culture and do not change their diploid karyotype61. Their proliferation can be stimulated by various growth factors, among which fibroblast growth factor 2 (FGF-2) is most important and required for their self-renewal62, 63, 64. The proliferation of ASC can also be stimulated by platelet-derived growth factor (PDGF) and oncostatin M65, 66. ASC proliferation can also be stimulated by growth factors supplemented by thrombin-activated platelet-rich plasma67, human platelet lysate68, and human thrombin69.
Differentiation potential of ASC
Adipose-derived stem cells have the capacity to differentiate into mesoderm, ectoderm, and endoderm lineage cells, although they are of mesodermal origin70, 71. It is known that they can differentiate into adipogenic72, 73,74, osteogenic75, chondrogenic75, 76, 77, myogenic78, cardiomyogenic79, 80, angiogenic81, tenogenic82, and periodontogenic lineages83. There have been few studies published regarding their ectodermal differentiation potential. Brzoska and Long et al., described epithelial differentiation of cultured ASC, which express the epithelial markers e.g., cytokeratins 8 and 18, and E-cadherin84, 85. In another study, Vossmerbaeumer et al., described differentiation of ASC toward retinal pigmented epithelium, which is of ectodermal origin86. It has also been demonstrated that ASC, under cultured conditions, can differentiate into neuronal or neuronal precursor cells87.
Intravenous administration of ASC in animal models on brain ischemia or hemorrhage demonstrated functional and histological improvement88, 89. In addition, recent studies have revealed a beneficial effect of intravenously administered ASC in animals with a spinal cord injury since they migrated and partially differentiated into neurons and oligodendrocytes, and restored locomotor function90.
Last but not least, it has been demonstrated that ASC can differentiate into endoderm lineage cells. It has been published that ASC have the potential to differentiate into hepatocytes91, 92, which raises the possibility for them to be used to reduce liver inflammation and treat liver fibrosis. In addition to hepatic differentiation, ASC under in vitro conditions can differentiate in insulin, glucagon, and somatostatin producing cells93, 94.
Apoptosis and cellular senescence (damaged cells that have lost the ability to divide) are considered to be important factors in ageing and age-related diseases. Dead cells are replaced by new in the process of regeneration. They originate from stem cells, although their proliferating/differentiating capacity depends on the age of the donor; as we age, the proliferation capacity of stem cells diminishes and leads to senescence.
Rejuvenation and ageing deceleration could be achieved by elimination of senescent cells, but their epigenetic reprogramming is not yet fully understood. Another approach to reset ‘the ageing-clock’ and to improve chronological ageing is to replace stem cells either through intravenous or local administration95.
Adult adipose-derived stem cells seem to be a powerful tool in regenerative medicine since they can differentiate into all three embryonic tissues. It has been published that the number of isolated stem cells per gram of processed adipose tissue is greater than that derived from bone marrow, which is another advantage for use in regenerative medicine60. Routinely, 1 x 107 adipose stromal/stem cells have been isolated from 300 ml of lipoaspirate, with greater than 95% purity96. The average frequency of ASC in processed lipoaspirate is 2% of all nucleated cells97.
Adipose-derived stem cells can be harvested by minimal abdominal liposuction performed with local anaesthesia, and processed by medical devices, which ideally should be part of closed, sterile, and standardized systems, to avoid toxicity, pyrogenicity, hemolysis, sensitization and genotoxicity, as well as to maintain their viability.
Adipose-derived stem cells are currently used in reconstructive and aesthetic medicine. They are used as a heterogenous cell suspension of SVF in breast augmentation and craniofacial soft tissue and bone restoration by their local application into the breast and the face. They can also be used in patients with severe heart failure by injecting them in coronary arteries, and in patients with musculoskeletal disorders by injecting into affected joints, although those treatments are not standardized and widely accepted. In addition, there are many clinical trials on their use in various conditions, such as peripheral vascular diseases, fistulas, diabetes mellitus, liver cirrhosis, lipodystrophy, spinal cord injury, faecal incontinence, degenerative arthritis, radiation ulcers, and graft-versus-host disease (GVHD)70. Last, but not least, the author believes that they can be successfully used in anti-ageing medicine to decelerate ageing.
As we age, our stem cells lose the ability to self-renew and to differentiate and consequently to replace aged cells with new ones (diminished regeneration). ASC communicate with surrounding cells by secreting cytokines and growth factors and differentiating into them. Their secreting cytokine profile is similar to the cytokines that are present in the local environment around them (e.g. bones, cartilage, tendons, muscles, skin) and as such maintain tissue regeneration.
Is has also been well reported, that ASC has beneficial effect on lipografts. The main side-effect of autologous lipotransfer is unpredictable graft resorption due to ischaemia and insufficient neoangiogenesis, which may ranges from 25%-80%. This is inconvenient because a number of procedures need to be performed before a satisfactory cosmetic outcome is achieved.
A review of the literature on autologous fat breast augmentation found 36 papers (1500 healthy women have been included, average follow up period was 16 months). The average breast volume gain was reported to range from 55%–82%. To overcome the problem of unpredictable results, autologous fat grafts have been enriched with ASC before transplantation. Four murine and three human studies on autologous lipotransfer have been found. ASC-enriched fat grafts (compared to non-enriched grafts) resulted in considerably improved fat graft survival (due to increased neovascularization and decreased inflammation) as well as quality (with minimal resorption rate), although too many ASC in grafts promoted graft necrosis, and the formation of vacuoles and fibrosis. It has been found in an murine model that 3 x 105 of ADS/ml of grafted fat has been shown to be the optimal concentration estimated by maximized desirable and minimized undesirable effects98.
Adult adipose-derived stem cells (ASC) seem to be a powerful tool in anti-aging and regenerative medicine since they can differentiate into all three embryonic tissues and secrete many cytokines and growth factors. Currently there are many clinical trials on their usage in various conditions, and results are promising. They can be harvested by minimal liposuction in autologous donors and administer locally or intravenously on the same day without previous genetic manipulation or their expansion in in vitro conditions. It has also been well established that number of adipose-derived stem cells per gram of processed adipose tissue is much greater than in bone marrow, which is another advantage in their usage.
Declaration of interest The authors report no conflicts of interest.
- Butler RN, Miller RA, Perry D et al. New model of health promotion and disease prevention for the 21st century. BMJ 2008; 337:a339
- Ernster VL, Grady D, Miike R et al. Facial wrinkling in men and women, by smoking status. Am J Public Health 1995; 85:78–82
- Farage MA, Miller KW, Elsner P et al. Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci 2008; 30:87–95
- Sinclair DA, Oberdoerffer P. The ageing epigenome: Damaged beyond repair? Ageing Res Rev 2009; 8: 189–98
- Beckman KB, Ames BN. The free radical theory of ageing matures. Physio Rev 1998; 78: 547–81
- Farage MA, Miller KW, Maibach HI. Textbook of ageing skin. Berlin: Springer-Verlag, 2010
- Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol 2011; 29:3–14
- Belicchi M, Pisati F, Lopa R et al. Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res 2004; 77: 475–86
- Feng J, Mantesso A, Sharpe PT. Perivascular cells as mesenchymal stem cells. Expert Opin Biol Ther 2010; 10: 1441–51
- Lenoir N. Europe confronts the embryonic stem cell research challenge. Science 2000; 287: 1425–7
- Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011; 11:268–77
- Song L, Young NJ, Webb NE et al. Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev 2005; 14:712–21
- Choi YS, Noh SE, Lim SM et al. Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnol Lett 2008; 30:593–601
- De Bari C, Dell’Accio F, Tylzanowski P et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001; 44:1928–42
- Dodson MV, Hausman GJ, Guan L et al. Skeletal muscle stem cells from animals I. Basic cell biology. Int J Biol Sci 2010; 6:465–74
- Belicchi M, Pisati F, Lopa R et al. Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res 2004; 77:475–86
- Feng J, Mantesso A, Sharpe PT. Perivascular cells as mesenchymal stem cells. Expert Opin Biol Ther 2010; 10:1441–51
- Shi M, Ishikawa M, Kamei N et al. Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived cd133-positive cells. Stem Cells 2009; 27:949–60
- Miura M, Gronthos S, Zhao M et al. Shed: Stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 2003; 100:5807–12
- Seo BM, Miura M, Gronthos S et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004; 364:149–55
- Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25:1384–92
- Musina RA, Bekchanova ES, Sukhikh GT. Comparison of mesenchymal stem cells obtained from different human tissues. Bull Exp Biol Med 2005; 139:504–9
- Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211–28
- Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100:1249–60
- Tobita M, Orbay H, Mizuno H. Adipose-derived stem cells: Current findings and future perspectives. Discov Med 2011; 11:160–70
- Yoshimura K, Suga H, Eto H. Adipose-derived stem/progenitor cells: Roles in adipose tissue remodeling and potential use for soft tissue augmentation. Regen Med 2009; 4:265–73
- Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796–808
- Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821–30
- Schipper BM, Marra KG, Zhang W et al. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg 2008; 60:538–44
- Prunet-Marcassus B, Cousin B, Caton D et al. From heterogeneity to plasticity in adipose tissues: Site-specific differences. Exp Cell Res 2006; 312:727–36
- Seale P, Bjork B, Yang W et al. Prdm16 controls a brown fat/skeletal muscle switch. Nature 2008; 454:961–7
- Zimmerlin L, Donnenberg VS, Pfeifer ME et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 2010; 77:22–30
- Bailey AM, Kapur S, Katz AJ. Characterization of adipose-derived stem cells: An update. Curr Stem Cell Res Ther 2010; 5:95–102
- Basciano L, Nemos C, Foliguet B et al. Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status. BMC Cell Biol 2011;12:12
- Bernardo ME, Zaffaroni N, Novara F et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67: 9142–9
- Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000;28:875–84
- Folgiero V, Migliano E, Tedesco M et al. Purification and characterization of adipose-derived stem cells from patients with lipoaspirate transplant. Cell Transplant 2010; 19:1225–35
- Freitas CS, Dalmau SR. Multiple sources of non-embryonic multipotent stem cells: Processed lipoaspirates and dermis as promising alternatives to bone-marrow-derived cell therapies. Cell Tissue Res 2006; 325:403–11
- Gronthos S, Franklin DM, Leddy HA et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001; 189:54–63
- Jones EA, English A, Kinsey SE et al. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom 2006; 70:391–9
- Katz AJ, Tholpady A, Tholpady SS et al. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hadas) cells. Stem Cells 2005; 23:412–23
- Meyerrose TE, De Ugarte DA, Hofling AA et al. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 2007; 25:220–7
- Mitchell JB, McIntosh K, Zvonic S et al. Immunophenotype of human adipose-derived cells: Temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006;24:376–85
- Yoshimura K, Shigeura T, Matsumoto D et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006; 208:64–76
- Alipour R, Sadeghi F, Hashemi-Beni B et al. Phenotypic characterizations and comparison of adult dental stem cells with adiposederived stem cells. Int J Prev Med 2010; 1:164–71
- Delorme B, Ringe J, Gallay N et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 2008; 111:2631–35
- Kim YJ, Yu JM, Joo HJ et al. Role of cd9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells. Pflugers Arch 2007; 455: 283–96
- Wagner W, Wein F, Seckinger A et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005; 33:1402–16
- Suga H, Matsumoto D, Eto H et al. Functional implications of cd34 expression in human adipose-derived stem/progenitor cells. Stem Cells Dev 2009; 18:1201–10
- Tang W, Zeve D, Suh JM et al. White fat progenitor cells reside in the adipose vasculature. Science 2008; 322:583–6
- Traktuev DO, Merfeld-Clauss S, Li J et al. A population of multipotent cd34 positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008; 102: 77–85
- Jeon BG, Kumar BM, Kang EJ et al. Characterization and comparison of telomere length, telomerase and reverse transcriptase activity and gene expression in human mesenchymal stem cells and cancer cells of various origins. Cell Tissue Res 2011; 345:149–61
- Puissant B, Barreau C, Bourin P et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129:118–29
- Van Poll D, Parekkadan B, Borel Rinkes I et al. Mesenchymal stem cell therapy for protection and repair of injured vital organs. Cell Mol Bioeng 2008; 1:42–50
- Kim WS, Park BS, Sung JH. Protective role of adipose-derived stem cells and their soluble factors in photoaging. Arch Dermatol Res 2009; 301:329–36
- Rehman J, Traktuev D, Li J et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109:1292–8
- Salgado AJ, Reis RL, Sousa NJ et al. Adipose tissue derived stem cells secretome: Soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010; 5:103–10
- Kilroy GE, Foster SJ, Wu X et al. Cytokine profile of human adipose-derived stem cells: Expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007; 212:702–9
- De Ugarte DA, Morizono K, Elbarbary A et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003; 174:101–9
- Izadpanah R, Trygg C, Patel B et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 2006; 99:1285–97
- 61. Rodriguez AM, Elabd C, Delteil F et al. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem Biophys Res Commun 2004;315:255–63
- Hebert TL, Wu X, Yu G et al. Culture effects of epidermal growth factor (egf) and basic fibroblast growth factor (bfgf) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis. J Tissue Eng Regen Med 2009;3: 553–61
- Kras KM, Hausman DB, Martin RJ. Tumor necrosis factor-alpha stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: Promotion of adipose tissue expansion by paracrine growth factors. Obes Res 2000; 8:186–93
- Zaragosi LE, Ailhaud G, Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adiposederived stem cells. Stem Cells 2006; 24:2412–9
- Kang YJ, Jeon ES, Song HY et al. Role of c-jun N-terminal kinase in the pdgf-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 2005; 95: 1135–45.
- Song HY, Jeon ES, Jung JS et al. Oncostatin m induces proliferation of human adipose tissue-derived mesenchymal stem cells. Int J Biochem Cell Biol 2005; 37:2357–65
- Kakudo N, Minakata T, Mitsui T et al. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg 2008; 122:1352–60
- Blande IS, Bassaneze V, Lavini-Ramos C et al. Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 2009; 49:2680–5
- Freyberg S, Song YH, Muehlberg F et al. Thrombin peptide (tp508) promotes adipose tissue-derived stem cell proliferation via pi3 kinase/akt pathway. J Vasc Res 2009; 46:98–102
- Mizuno H. Adipose-derived stem and stromal cells for cell-based therapy: Current status of preclinical studies and clinical trials. Curr Opin Mol Ther 2010; 12:442–9
- Zuk PA. The adipose-derived stem cell: Looking back and looking ahead. Mol Biol Cell 2010; 21:1783–7
- Brayfield CA, Marra KG, Rubin JP. Adipose tissue regeneration. Curr Stem Cell Res Ther 2010; 5:116–21
- Cherubino M, Marra KG. Adipose-derived stem cells for soft tissue reconstruction. Regen Med 2009; 4:109–17
- Rubin JP, Marra KG. Soft tissue reconstruction. Methods Mol Biol 2011; 702: 395–400
- Dragoo JL, Samimi B, Zhu M et al. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 2003; 85:740–7
- Estes BT, Diekman BO, Gimble JM et al. Isolation of adipose derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 2010; 5:1294–311
- Estes BT, Guilak F. Three-dimensional culture systems to induce chondrogenesis of adipose-derived stem cells. Methods Mol Biol 2011; 702:201–17
- Mizuno H, Zuk PA, Zhu M et al. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 2002; 109:199–209; discussion 210–191
- Lee WC, Sepulveda JL, Rubin JP et al. Cardiomyogenic differentiation potential of human adipose precursor cells. Int J Cardiol 2009; 133:399–401
- Planat-Benard V, Menard C, Andre M et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004; 94:223–9
- Cherubino M, Rubin JP, Miljkovic N et al. Adipose-derived stem cells for wound healing applications. Ann Plast Surg 2011; 66:210–15
- Uysal AC, Mizuno H. Tendon regeneration and repair with adipose derived stem cells. Curr Stem Cell Res Ther 2010; 5: 161–7
- Tobita M, Mizuno H. Periodontal disease and periodontal tissue regeneration. Curr Stem Cell Res Ther 2010; 5: 168–74
- Brzoska M, Geiger H, Gauer S et al. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 2005; 330: 142–50
- Long JL, Zuk P, Berke GS et al. Epithelial differentiation of adipose-derived stem cells for laryngeal tissue engineering. Laryngoscope 2010; 120: 125–31
- Vossmerbaeumer U, Ohnesorge S, Kuehl S et al. Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells. Cytotherapy 2009; 11:177–88
- Safford KM, Safford SD, Gimble JM et al. Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells. Exp Neurol 2004; 187: 319–28
- Ikegame Y, Yamashita K, Hayashi S et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 2011; 13:675–85
- Kim JM, Lee ST, Chu K et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007; 1183:43–50
- Kang SK, Shin MJ, Jung JS et al. Autologous adipose tissue-derived stromal cells for treatment of spinal cord injury. Stem Cells Dev 2006; 15:583–94
- Aurich H, Sgodda M, Kaltwasser P et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009; 58:570–81
- Banas A, Teratani T, Yamamoto Y et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 2009; 24:70–7
- Chandra V, Swetha G, Phadnis S et al. Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells. Stem Cells 2009; 27:1941–53
- Timper K, Seboek D, Eberhardt M et al. Human adipose tissue derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006; 341: 1135–40
- Sikora E, Bielak-Zmijewska A, Mosieniak G. Cellular Senescence in Ageing, Age-Related Disease and Longevity. Curr Vasc Pharmacol 2014; 12: 698-706
- Boquest AC, Shahdadfar A, Brinchmann JE et al. Isolation of stromal stem cells from human adipose tissue. Methods Mol Biol 2006; 325: 35–46
- Strem BM, Hicok KC, Zhu M et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005; 54: 132–41
- Kakudo N, Tanaka Y, Morimoto N, et al. Adipose-derived regenerative cell (ADRC)-enriched fat grafting: optimal cell concentration and effects on grafted fat characteristics. J Translat Med 2013; 11:254